A baseline metabolomic signature is associated with immunological CD4+ T-Cell recovery after 36 months of art in HIV-infected patients
Esther Rodríguez‐Gallego(Institut de Recerca Biomèdica Catalunya Sud), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Verònica Alba, Anna Rull(Institut de Recerca Biomèdica Catalunya Sud), Yolanda M. Pacheco(Instituto de Biomedicina de Sevilla), Josep Gómez(Hospital Universitari Joan XXIII de Tarragona), Peré Domingo(Hospital de Sant Pau), Nicolau Cañellas(Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas), Consuelo Viladés(Hospital Universitario Fundación Jiménez Díaz), Xavier Correig(Universidad Rovira i Virgili), Julià Blanco(IrsiCaixa), Sergio Veloso(Hospital Terrassa), Miguel López-Dupla, M. Leal(Instituto de Biomedicina de Sevilla), Roger Mallol(Institut d'Investigació Sanitària Pere Virgili), Joaquim Peraire(Instituto de Salud Carlos III), Raúl Beltrán‐Debón(Institut de Recerca Biomèdica Catalunya Sud)
Cited by 0
Related Papers
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
|Mucosal Immunology|2014|332
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV‐1 envelope
|The EMBO Journal|2002|147
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
|The Lancet Infectious Diseases|2015|143
Relationship between current level of immunodeficiency and non‐acquired immunodeficiency syndrome‐defining malignancies
|Cancer|2010|141
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|137